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The microcephaly epidemic in Brazil generated intense debate regarding its causality, and one hypothesised 
cause of this epidemic, now recognised as congenital Zika virus syndrome, was the treatment of drinking water 
tanks with pyriproxyfen to control Aedes aegypti larvae. We present the results of a geographical analysis of the as-
sociation between the prevalence of microcephaly confirmed by Fenton growth charts and the type of larvicide used 
in the municipalities that were home to the mothers of the affected newborns in the metropolitan region of Recife in 
Pernambuco, the state in Brazil where the epidemic was first detected. The overall prevalence of microcephaly was 
82 per 10,000 live births in the three municipalities that used the larvicide Bti (Bacillus thuringiensis israelensis) 
instead of pyriproxyfen, and 69 per 10,000 live births in the eleven municipalities that used pyriproxyfen. The dif-
ference was not statistically significant. Our results show that the prevalence of microcephaly was not higher in the 
areas in which pyriproxyfen was used. In this ecological approach, there was no evidence of a correlation between 
the use of pyriproxyfen in the municipalities and the microcephaly epidemic.
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One of the controversies regarding the aetiology of 
the microcephaly epidemic in Northeast Brazil, which 
was recognised to be associated with Zika virus infec-
tion (Rasmussen et al. 2016, WHO 2016), was the po-
tential harm associated with the use of pyriproxyfen in 
drinking water tanks as a larvicide against Aedes aegyp-
ti (ABRASCO 2016). The Brazilian Ministry of Health 
(MoH) responded to the hypothesised association with the 
statement, “There are no epidemiological studies showing 
the association between use of pyriproxyfen and micro-
cephaly”. Pyriproxyfen is a pyridine-based broad-spec-
trum larvicide that functions as an insect growth regulator 
and is effective against a variety of harmful insects. It was 
originally used in agricultural pest control (WHO 2008). 
Pyriproxyfen was approved as a pesticide by the World 
Health Organisation (WHO) and the Brazilian regulato-
ry agency ANVISA. However, suspicions regarding its 
safety remained (Bar-Yam et al. 2016, Evans et al. 2016), 
and the state of Rio Grande do Sul, in Brazil, suspended 
the use of pyriproxyfen in February 2016 (EBC 2016). A 
recent review of the literature evaluating the safety of py-
riproxyfen revealed a lack of data, preventing an adequate 
risk assessment of the potential role of pyriproxyfen in the 
induction of microcephaly (SWETOX 2016).
Pernambuco was the first state in Brazil to detect an 
increase in the number of cases of microcephaly com-
pared to previous years, and it remains the region most 
affected by the epidemic (Brasil 2016). In Pernambuco, 
chemical larvicide (pyriproxyfen) or biological larvicide 
(Bacillus thuringiensis israelensis - Bti) were used in 
two distinct groups of municipalities, according to the 
vector control programs (CES 2016).
The current study aimed to explore the possible as-
sociation between the prevalence of microcephaly, reg-
istered during the epidemic, and the use of chemical or 
biological larvicide in the metropolitan region of Recife 
(MRR), in Pernambuco state, Brazil.
The MRR is composed of 14 municipalities, with a 
population of 3,743,854 in 2012 (DATASUS - http://tab-
net.datasus.gov.br/cgi/tabcgi.exe?ibge/cnv/poppe.def). 
According to the State Department of Health data from 
2014 and 2015, three municipalities, Recife, Jaboatão 
and Paulista, used Bti, while the others employed py-
riproxyfen (CES 2016). We obtained data regarding no-
tifications of microcephaly from the State Department 
of Health Surveillance System for the period between 
2 August 2015, and 3 April 2016. To define a case of 
microcephaly, we used Fenton growth curves with a cut-
off of -2 standard deviations (SD) below the mean value 
for newborn head circumference (not the criteria bellow 
the 3rd percentile). This is very close, but not exactly the 
same as the intergrowth standards, which is now recom-
mended to for the assessment of microcephaly (Victora 
2016). The number of newborns in the study period was 
estimated as a proportion (eight months) of the annual 
number of births in the year 2013 by municipalities (SI-
NASC)/MoH (DATASUS - http://tabnet.datasus.gov.br/
Pyriproxyfen and the microcephaly epidemic • Maria de Fatima P Militão de Albuquerque et al. 775
TABLE
Prevalence of microcephaly according to the type of larvicide used by  
municipalities of Recife metropolitan region, Pernambuco, Brazil
Municipalities / larvicide Cases Newborns Prevalence per 10,000
Bacillus thuringiensis israelensis
Recife 124 15,451 80.3
Jaboatão 56 6,474 86.5
Paulista 22 2,756 79.8
Sub-total 202 24,681 81.8
Pyriproxyfen
Olinda 18 4,013 44.9
Cabo de Sto. Agostinho 13 2,279 57.0
Camaragibe 14 1,572 89.1
S Lourenço da Mata 13 1,133 114.8
Igarassu 7 1,090 64.2
Ipojuca 14 1,066 131.3
Abreu e Lima 4 1,021 39.2
Moreno 5 543 92.0
Itapissuma 2 240 83.3
Araçoiaba 1 237 42.1
Ilha de Itamaracá 2 217 92.0
Sub-total 93 13,412 69.3
Total 295 38,093 77.4
c2 = 1.61; df = 1; p = 0.21
cgi/deftohtm.exe?sinasc/cnv/nvpe.def). This number was 
used as the denominator to calculate the prevalence rates 
according to the mother’s municipality of residence. We 
tested the difference in the prevalence of microcephaly 
for the two groups of municipalities: those exposed to py-
riproxyfen versus those not exposed.
We calculated the risk ratio and 95% confidence in-
terval (CI) with a significance level given by the c2 test 
with Yates correction. During the study period, there 
were 719 reported cases, with 295 (41%) cases con-
firmed by the Fenton criteria.
Table presents, for each municipality, the proportion 
of newborns with microcephaly born to mother who 
were residents of that municipality and indicates wheth-
er pyriproxyfen was used in the drinking water tanks 
in that municipality. The three municipalities in which 
Bti was used had an overall prevalence of microcephaly 
of 82 per 10,000 live births, which was not statistical-
ly significantly different from the prevalence of 69 per 
10,000 live births in the 11 municipalities that utilised 
pyriproxyfen. The risk ratio obtained was 0.85 (95% CI, 
0.66-1.08; p = 0.21). Figure displays the spatial distribu-
tion of microcephaly prevalence per 10,000 live births 
according to the municipalities of the MRR.
Our results show that the prevalence of microcephaly 
was not higher in the areas in which pyriproxyfen was 
used. In this ecological approach, there was no evidence 
of a correlation between the use of this larvicide in the 
municipalities and the epidemic of microcephaly. This 
study is relevant to document the lack of an association, 
and we hope it is also a good example of the use of rou-
tine data to test a hypothesis. One limitation of this study 
is that the spatial units are large and populous. There 
may be a certain degree of heterogeneity in the vector 
control activities at the neighbourhood and house lev-
els. Nevertheless, only one type of larvicide was used in 
each municipality during the reference period.
Considering that this was an ecological study, we 
do not have information regarding exposure on disag-
gregated levels. We compared areas exposed to pyri-
proxyfen to areas not exposed to pyriproxyfen to test 
if there was an association between pyriproxyfen and 
microcephaly at the ecological level. However, our find-
ings do not invalidate the argument that improvements 
in environmental management to prevent and control 
disease may be a better choice than the widespread use 
of larvicide in drinking water for vector control, nor do 
they exclude other potential toxicities of pyriproxyfen 
(ABRASCO 2016). In addition, it should be noted that 
the mosquito vector control strategies during the past 
three decades, mainly based on chemical insecticides 
and larvicides, have proven ineffective (Regis et al. 2014, 
Augusto et al. 2016). Moreover, it is necessary to inves-
tigate other potential toxicities of pyriproxyfen. Despite 
approval from regulatory agencies (WHO 2006), further 
research may be needed to exclude other negative health 
outcomes, since during the Zika epidemic (and the po-
tential emergence of other arboviruses), this product 
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might be applied even more widely to drinking water 
for vector control. We emphasise that our findings seem 
timely because the analysis was performed in a region in 
which the microcephaly epidemic was most severe, and 
for which information was available on the use of chemi-
cal or biological larvicide by municipalities.
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